Department of Anesthesiology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY.
Department of Anesthesiology, Weill Cornell Medicine, New York-Presbyterian Hospital, New York, NY.
J Cardiothorac Vasc Anesth. 2020 Dec;34(12):3267-3274. doi: 10.1053/j.jvca.2020.06.006. Epub 2020 Jun 10.
To determine the effect of preoperative opioid use disorder (OUD) on postoperative outcomes in patients undergoing coronary artery bypass grafting (CABG) and heart valve surgery.
Retrospective, observational study using data from the State Inpatient Database and the Healthcare Cost and Utilization Project.
Inpatient data from Florida, California, New York, Maryland, and Kentucky between 2007 and 2014.
A total of 377,771 CABG patients and 194,469 valve surgery patients age ≥18 years.
None.
The prevalence of OUD was 2,136 (0.57%) in the CABG group and 2,020 (1.04%) in the valve surgery group. There was no significant difference in mortality between the OUD and non-OUD groups in both surgical cohorts (both p > 0.05). On adjusted analyses, preoperative OUD was significantly associated with increased adjusted odds ratios (aORs) of 30-day hospital readmission (CABG aOR 1.47 [95% confidence interval {CI} 1.30-1.66]; valve surgery aOR 1.41 [95% CI 1.27-1.56]) and 90-day hospital readmission (CABG aOR 1.47 [95% CI 1.31-1.64]; valve surgery aOR 1.33 [95% CI 1.23-1.43]). Preoperative OUD was significantly associated with increased adjusted risk ratios (aRRs) of hospital length of stay (CABG aRR 1.13 [95% CI 1.10-1.16]; valve surgery aRR 1.63 [95% CI 1.54-1.72]) and total hospitalization charges (CABG aRR 1.05 [95% CI 1.03-1.07]; valve surgery aRR 1.28 [95% CI 1.24-1.32]).
Preoperative OUD is significantly associated with poorer outcomes after cardiac surgery, including increased 30- and 90-day readmissions, hospital length of stay, and total hospitalization charges. Opioid use should be considered a modifiable risk factor in cardiac surgery, and interventions should be attempted preoperatively.
确定术前阿片类药物使用障碍(OUD)对接受冠状动脉旁路移植术(CABG)和心脏瓣膜手术患者术后结局的影响。
使用来自州内住院患者数据库和医疗保健成本与利用项目的数据进行回顾性、观察性研究。
2007 年至 2014 年间,佛罗里达州、加利福尼亚州、纽约州、马里兰州和肯塔基州的住院患者数据。
共有 377771 例 CABG 患者和 194469 例年龄≥18 岁的瓣膜手术患者。
无。
CABG 组中有 2136 例(0.57%)和瓣膜手术组中有 2020 例(1.04%)患者存在 OUD。两组中 OUD 组和非 OUD 组的死亡率均无显著差异(均 p > 0.05)。在调整分析中,术前 OUD 与 30 天住院再入院的调整后优势比(aOR)显著相关(CABG aOR 1.47 [95%置信区间 {CI} 1.30-1.66];瓣膜手术 aOR 1.41 [95% CI 1.27-1.56])和 90 天住院再入院(CABG aOR 1.47 [95% CI 1.31-1.64];瓣膜手术 aOR 1.33 [95% CI 1.23-1.43])。术前 OUD 与住院时间(CABG aRR 1.13 [95% CI 1.10-1.16];瓣膜手术 aRR 1.63 [95% CI 1.54-1.72])和总住院费用(CABG aRR 1.05 [95% CI 1.03-1.07];瓣膜手术 aRR 1.28 [95% CI 1.24-1.32])的调整风险比(aRR)显著相关。
术前 OUD 与心脏手术后较差的结果显著相关,包括 30 天和 90 天的再入院率增加、住院时间延长和总住院费用增加。阿片类药物的使用应被视为心脏手术的可改变风险因素,并应尝试在术前进行干预。